Anthony Criquet
Genetics & Molecular Biology
Cell Prothera
Australia
Biography
Since May 2012, he is actively defining the development of CellProthera’s therapy and prepares the international clinical trial. Medical Doctor, specialized in cardiology and hematology, he has a well-established experience in the medical and pharmaceutical fields. These last ten years, he managed the development and marketing of compounds of various pharmaceutical companies such as BAYER, TEVAPHARMA (Neurology, multiple sclerosis, biosimilars, and cellular therapy) or MUNDIPHARMA (Onco-Hematology).
Research Interest
Stem Cell
